“Is that smoke, where’s it coming from?” No doubt about it. This news now breaking wind is guaranteed to spark a firestorm of classless action suits, although attorney doods, I don’t want to get anywhere near your conference rooms. Coincidentally, a brush fire is sweeping the Hollywood Hills threatening Universal City, Griffith Park, and the Prinz and Porno’s (Frederick & Marcus) favorite parking spot near the world’s most photographed billboard. No word on the cause of the fire? LOL. Now’s a good time to quit cigarettes. Kevin, bro, you really were on to something with that six degrees thing.

Swiss pharmaceutical maker Novartis AG will stop selling a drug to relieve constipation after it was linked to a higher chance of heart attack, stroke and worsening heart chest pain that can become a heart attack, federal health officials said Friday.

Novartis agreed to withdraw Zelnorm at the FDA’s request, the agency said in a public health advisory. Zelnorm, also called tegaserod maleate, is a prescription medication approved for short-term treatment of women with irritable bowel syndrome with constipation and for patients younger than 65 with chronic constipation, the FDA said. Doctors who prescribe Zelnorm should work with their patients and transition them to other therapies as appropriate, the FDA added. Oh. I got it. Constipation is now appropriate. Thank you, FDA.

Be worried. Be very very worried.